China
Africa
Explore chapters and articles related to this topic
Introduction
Published in Felicity Goodyear-Smith, Bob Mash, Michael Kidd, International Perspectives on Primary Care Research, 2017
In 1990, the Commission on Health Research for Development coined the term '90:10 gap' to capture the mismatch between research funding and health priorities globally, arguing that 90" of research funding globally went to address 10" of the extant burden of disease. Some have argued that the new institutional environment has generated problems of its own, related to the lack of accountability of these large funders and to their impacts on national health systems. Traditional multilateral organisations supporting health research, such as the World Health Organization (WHO) and UNICEF, have been eclipsed in this funding environment in which multiple bilateral financing mechanisms, involving a few powerful governments partnering with philanthropic foundations and non-governmental organisations, have realigned the objectives of these multilateral organisations to match their own agendas. This allows powerful governments to use funding mechanisms as a way to define a separate mandate and to push specific goals.
Ethical considerations of global health partnerships *
Published in Andrew D. Pinto, Ross E.G. Upshur, An Introduction to Global Health Ethics, 2013
Jill Murphy, Victor R. Neufeld, Demissie Habte, Abraham Aseffa, Kaosar Afsana, Anant Kumar, Maria de Lourdes Larrea, Jennifer Hatfield
Such challenges are reflective of the ‘10/90 Gap’, where only 10 per cent of research funding is directed to health challenges that 90 per cent of the world's populations face (Commission on Health Research for Development 1990). Research funding is heavily weighted in favour of HICs, causing challenges to equity in health research. This can be seen throughout global health policy and practice.
Bioethics, (Funding) Priorities, and the Perpetuation of Injustice
Published in The American Journal of Bioethics, 2022
Rachel Fabi, Daniel S. Goldberg
How organizations allocate their resources is a reasonable indicator of an organization’s priorities, and these allocation decisions are arguably subject to ethical critique. In bioethics in particular, the most prominent body of work addressing this concern generally relates to research allocation. For example, in 1990 the Commission on Health Research and Development ignited discussion on the so-called “10–90 gap,” drawing attention to the fact that “less than 10% of global funding for research is spent on diseases that afflict more than 90% of the world's population” (Vidyasagar 2006). In 2005, Michael Selgelid decried an analogous 10–90 gap within the field of bioethics, observing that 90% of what Western bioethicists discuss is relevant to 10% of the world’s health problems (Selgelid 2005; see also Farmer and Campos 2004).